Peptide MGF (5 mg) PeptideSciences
oxyPharma
Cena na zapytanie
Zobacz więcejoxyPharma
Tirsepatide Tirsepatide (16 mg) PeptideSciences
Cena na zapytanie
Tirzepatide 16 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 16 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising treat
● Niedostępny
1
Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines the action of two incretin hormones in a single peptide. By stimulating insulin secretion after meals and suppressing glucagon secretion between meals, it supports both post-meal and fasting blood sugar stability while also acting on appetite centers to reduce hunger. This PeptideSciences vial contains 16 mg of Tirzepatide, suited to a longer or higher-dose protocol.
This dual mechanism gives Tirzepatide a stronger overall metabolic effect than single-pathway peptides, supporting significant, gradual weight loss alongside improved glycemic control and cardiovascular support.
Key Benefits
- Dual GIP/GLP-1 action for stronger glycemic and appetite control than single-receptor peptides
- Suppresses appetite and increases satiety, supporting gradual weight loss
- Stabilizes blood glucose both after meals and between meals
- Supports cardiovascular health markers relevant to metabolic patients
- Larger 16 mg vial reduces reorder frequency for users on an extended protocol
Opinie (0)
Brak opinii.
Podobne produkty
GHRP peptide 2 (5 mg) Nordex
oxyPharma
Cena na zapytanie
Zobacz więcejHexarelin Peptide (2 mg) CanadaPeptides
oxyPharma
Cena na zapytanie
Zobacz więcejGHRP Peptide 6 (5 mg) Nanox
oxyPharma
Cena na zapytanie
Zobacz więcej